Milrinone
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Milrinone and local guidelines before prescribing.
Inodilator
Mechanism
Phosphodiesterase-3 inhibitor.
Uses
Acute heart failure with low output.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypotension, arrhythmias, thrombocytopenia.
Interactions
Other inotropes.
Contraindications and cautions
Severe aortic stenosis
Monitoring
BP, ECG
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Used when on beta-blockers; reduce dose in renal impairment.
More from the textbook: uses, cautions and other points
- Vasoactive drugs : Drug Receptors Main effects and uses Noradrenaline Mainly α1 (some β1) Vasoconstriction — raises SVR and MAP — first-line vasopressor in septic shock Vasopressin V1 receptors Vasoconstriction — second-line added to noradrenaline in septic shock (noradrenaline-sparing) Adrenaline α and β (β at low doses) Inotrope and …
Critical care: Admission and organ support - Contractility (inotropy) - the strength of contraction at a given preload; increased by sympathetic stimulation and inotropes (dobutamine, adrenaline, milrinone, digoxin); reduced by beta-blockers, rate-limiting calcium channel blockers, ischaemia, acidosis and hypoxia.
Cardiology: Anatomy Physiology and Pharmacology - PDE3 inhibitors (milrinone) → less cAMP breakdown → same effect plus vasodilatation.
Cardiology: Anatomy Physiology and Pharmacology - Milrinone | PDE3 inhibitor - inotropy plus vasodilatation ("inodilator") | Low-output heart failure, after cardiac surgery; hypotension
Cardiology: Anatomy Physiology and Pharmacology - Milrinone (phosphodiesterase inhibitor), levosimendan (calcium sensitiser) - specialist.
Acute Medicine: Shock, sepsis and critical illness - Milrinone | Phosphodiesterase-3 inhibitor | Inodilator — heart failure, right ventricular failure, after cardiac surgery; hypotension
Critical care: Admission and organ support - Cardiogenic shock | Dobutamine or milrinone (inotropes)
Critical care: Admission and organ support
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Critical care: Admission and organ support (3 mentions)